CASI Pharmaceuticals CASIF
OTC CASIF
$0.13 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Current Leases (2021 - 2025)

Updated

CASI Pharmaceuticals (CASIF) posted Current Leases of $18.25 million for Q4 2025, down 19.9% from $22.79 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Current Leases (2021 - 2025) Analysis & Trends

Since Q4 2021, CASI Pharmaceuticals has reported Current Leases for 5 quarters.

  • Annual Current Leases shows a four-year compound annual growth rate of -4.7% (FY2021 to FY2025).
  • In prior years, CASI Pharmaceuticals' Current Leases was $22.79 million in FY2024 (-18.6%), $28 million in FY2023 (+23.7%), $22.62 million in FY2022 (+2.4%) and $22.08 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 CASI Pharmaceuticals 2.67 Mn -18.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18.25 Mn
Dec 31, 2024 22.79 Mn
Dec 31, 2023 28.00 Mn
Dec 31, 2022 22.62 Mn
Dec 31, 2021 22.08 Mn
API Access

CASI Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CASIF&period=max&api_key=YOUR_API_KEY